Telomir Pharmaceuticals, Inc.

US$0.71As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TELOHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (61.19%)
Div yield —
ROE (96.26%)
Biotechnology
Beta (5Y) (0.19)
PE TTM —
TSR TTM (54.48%)
Mkt cap US$52.28M
ROIC (61.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.686
(3.45%)
(49.69%)
Sell 1|8|8|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
24.56%
10.11%
12.10%
24.09%
Revenue$M
5.781
5.970
5.971
5.885
11.12%
11.41%
7.08%
0.12%
Peers (US$52.28M)
Cap (US$)
PE
52.40M
—
Capital
TTM
5Y
10Y
Leveragex
2.008
(0.027)
(0.024)
EBIT/Intx
0.388
1.116
1.007
Own earn%
(28.07)
(65.98)
(77.30)
Sh yield%
29.07
18.52
19.73
Owners
Insiders/Inst%
13.97
87.61
Short interest%
2.21
SBC / revenue%
5.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
12–17
$1 testx
0.1
Incr. ROIC%
16